Sulfacetamide sodium salt hydrate
CAS No. 6209-17-2
Sulfacetamide sodium salt hydrate ( —— )
产品货号. M15350 CAS No. 6209-17-2
Sulfacetamide sodium monohydrate is a sulfonamide antibiotic, has been investigated for use in the treatment of pityriasis versicolor and rosacea.
纯度: >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
25MG | ¥243 | 有现货 |
|
100MG | ¥421 | 有现货 |
|
200MG | ¥697 | 有现货 |
|
500MG | ¥1150 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Sulfacetamide sodium salt hydrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Sulfacetamide sodium monohydrate is a sulfonamide antibiotic, has been investigated for use in the treatment of pityriasis versicolor and rosacea.
-
产品描述Sulfacetamide sodium monohydrate is a sulfonamide antibiotic, has been investigated for use in the treatment of pityriasis versicolor and rosacea.
-
同义词——
-
通路Autophagy
-
靶点Autophagy
-
受体DHPS
-
研究领域Infection
-
适应症——
化学信息
-
CAS Number6209-17-2
-
分子量254.20
-
分子式C8H9N2NaO3S·H2O
-
纯度>98%(HPLC)
-
溶解度Soluble in Water
-
SMILESO.[Na].CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Hevener KE, et al. J Chem Inf Model. 2009 Jan 27.
产品手册
关联产品
-
ARN-5187
A novel lysosomotropic REV-ERB ligand that has a dual inhibitory activity toward REV-ERB-mediated transcriptional regulation and autophagy.
-
Sulfisoxazole
Sulfisoxazole, an endothelin receptor antagonist, is a sulfonamide antibacterial with an oxazole substituent.
-
MPP+ iodide
MPP+ iodide, the metabolite of a neurotoxin MPTP, causes symptom of Parkinson's disease (PD) in animal models by selectively destroying dopaminergic neurons in substantia nigra.